Immediate Impact
2 from Science/Nature 63 standout
Citing Papers
Multi drug resistance in Colorectal Cancer- approaches to overcome, advancements and future success
2024 Standout
Colorectal cancer
2024 Standout
Works of Usman Shah being referenced
Nivolumab (NIVO) + low-dose ipilimumab (IPI) as first-line (1L) therapy in microsatellite instability-high/mismatch repair-deficient (MSI-H/dMMR) metastatic colorectal cancer (mCRC): Two-year clinical update.
2020
Nivolumab (NIVO) + low-dose ipilimumab (IPI) as first-line (1L) therapy in microsatellite instability-high/DNA mismatch repair deficient (MSI-H/dMMR) metastatic colorectal cancer (mCRC): Clinical update.
2019
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Usman Shah | 66 | 214 | 111 | 92 | 32 | 397 | |
| Haixia Jia | 51 | 146 | 65 | 75 | 30 | 397 | |
| Jia Zhu | 54 | 118 | 60 | 59 | 64 | 382 | |
| Shu‐Yun Ma | 34 | 149 | 113 | 44 | 43 | 428 | |
| Han Liu | 81 | 83 | 29 | 53 | 38 | 385 | |
| Yajin Chen | 124 | 131 | 72 | 104 | 22 | 420 | |
| Jia-Bin Liao | 14 | 72 | 61 | 69 | 29 | 359 | |
| Linrong Li | 14 | 148 | 118 | 58 | 29 | 452 | |
| Chong Zhang | 89 | 129 | 28 | 61 | 26 | 445 | |
| Weiluo Cai | 39 | 111 | 32 | 103 | 22 | 386 | |
| Kui Meng | 73 | 60 | 36 | 62 | 29 | 416 |
All Works
Loading papers...